نتایج جستجو برای: montanide isa 61 vg

تعداد نتایج: 67947  

2009
Sheetij Dutta JoAnn S. Sullivan Katharine K. Grady J. David Haynes Jack Komisar Adrian H. Batchelor Lorraine Soisson Carter L. Diggs D. Gray Heppner David E. Lanar William E. Collins John W. Barnwell

A Plasmodium falciparum 3D7 strain Apical Membrane Antigen-1 (AMA1) vaccine, formulated with AS02(A) adjuvant, slowed parasite growth in a recent Phase 1/2a trial, however sterile protection was not observed. We tested this AS02(A), and a Montanide ISA720 (ISA) formulation of 3D7 AMA1 in Aotus monkeys. The 3D7 parasite does not invade Aotus erythrocytes, hence two heterologous strains, FCH/4 an...

Journal: :Journal of the American College of Cardiology 2005
Junya Ako Yoshihiro Morino Yasuhiro Honda Ali Hassan Shinjo Sonoda Paul G Yock Martin B Leon Jeffrey W Moses Heidi N Bonneau Peter J Fitzgerald

OBJECTIVES We sought to identify the frequency of incomplete stent apposition (ISA) in sirolimus-eluting stents (SES) and clarify its findings and clinical sequelae. BACKGROUND Late-acquired ISA has been reported in bare-metal stents (BMS) and brachytherapy and recently in drug-eluting stents. However, the characteristics of late ISA in SES have not been clarified. METHODS From the SIRIUS t...

2013
Bernhard Rieger Gerhard Jany Manfred Steimann Riad Fawzi

The chiral ligand precursor systems [l-C pM -R '-2-R 2-2-Cp2]ethane 5 a -d bearing two dif­ ferent cyclopentadienyl fragments (C p1, Cp2 = Cp, Ind, Flu) and a variable bridge substitu­ tion pattern (R 1, R2 = H, Ph, cyclopentyl, cyclohexyl) were prepared starting from the corre­ sponding epoxides. The solid state structures o f six organic intermediates are reported in order to prove the stereo...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2008
Gemma G Kenter Marij J P Welters A Rob P M Valentijn Margriet J G Lowik Dorien M A Berends-van der Meer Annelies P G Vloon Jan W Drijfhout Amon R Wafelman Jaap Oostendorp Gert Jan Fleuren Rienk Offringa Sjoerd H van der Burg Cornelis J M Melief

PURPOSE To determine the toxicity, safety, and immunogenicity of a human papillomavirus 16 (HPV16) E6 and E7 long peptide vaccine administered to end-stage cervical cancer patients. EXPERIMENTAL DESIGN Three groups of end-stage cervical cancer patients (in total n = 35) were s.c. vaccinated with HPV16 E6 combined with or separated from HPV16 E7 overlapping long peptides in Montanide ISA-51 ad...

2015
Fabien Aubry Antoine Nougairède Lauriane de Fabritus Géraldine Piorkowski Ernest A. Gould Xavier de Lamballerie Lisa F.P. Ng

Isolation of viral pathogens from clinical and/or animal samples has traditionally relied on either cell cultures or laboratory animal model systems. However, virus viability is notoriously susceptible to adverse conditions that may include inappropriate procedures for sample collection, storage temperature, support media and transportation. Using our recently described ISA method, we have deve...

Journal: :Revista do Instituto de Medicina Tropical de Sao Paulo 2012
Joshua M Mutiso John C Macharia Evans Taracha Kellern Wafula Hitler Rikoi Michael M Gicheru

In this study, we report on the safety and skin delayed-type hypersensitivity (DTH), responses of the Leishmania donovani whole cell sonicate antigen delivered in conjunction with alum-BCG (AlBCG), Montanide ISA 720 (MISA) or Monophosphoryl lipid A (MPLA) in groups of vervet monkeys. Following three intradermal injections of the inoculums on days 0, 28 and 42, safety and DTH responses were asse...

2012
Paul Sabbatini Takemasa Tsuji Luis Ferran Erika Ritter Christine Sedrak Kevin Tuballes Achim A. Jungbluth Gerd Ritter Carol Aghajanian Katherine Bell-McGuinn Martee L. Hensley Jason Konner William Tew David R. Spriggs Eric W. Hoffman Ralph Venhaus Linda Pan Andres M. Salazar Catherine Magid Diefenbach Sacha Gnjatic

Purpose: Long peptides are efficiently presented to both CD4þ and CD8þ T cells after intracellular processing by antigen-presenting cells. To investigate the safety and in vivo immunogenicity of synthetic overlapping longpeptides (OLP) fromahuman tumor self-antigen,we conducted aphase I clinical trialwith OLP from cancer-testis antigen NY-ESO-1 in various adjuvant combinations. Experimental Des...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2011
Marieke F Fransen Marjolein Sluijter Hans Morreau Ramon Arens Cornelis J M Melief

PURPOSE Immunotherapy against tumors with anti-CD40 agonistic antibodies has been extensively studied in preclinical animal models and recently also in clinical trials. Although promising results have been obtained, antibody (Ab)-related toxicity has been a limiting factor. We reasoned that strict local activation of tumor-specific CD8 T cells through stimulation of CD40 on the dendritic cells ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید